When Jim Cramer says “buy,” Wall Street listens. Retail traders sprint. And somewhere, a hedge fund quietly takes the other side. Now he’s bullish on Marvell (MRVL) and Bausch Health (BHC). Two very different beasts — one riding the AI semiconductor wave, the other dragging around a pharmaceutical debt hangover. So the question isn’t whether…